Concepedia

Atsushi Iwakaji

AI

Statistics

Publications

1

Citations

88

H-Index

1

Active since

2016

Affiliations

Mitsubishi Tanabe Pharma Corporation(Current)

Atsushi Iwakaji is an author at Mitsubishi Tanabe Pharma Corporation specializing in pharmacotherapy, molecular pharmacology, and schizophrenia.

Top concepts

Publications per year

2016–2016

1

Publications

1

Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment)

Tadakatsu Nakamura, Tomoko Kubota, Atsushi Iwakaji et al. · Drug Design Development and Therapy · 2016 · 88 citations · Full text

, , +16

1–1 of 1